Bone Marrow–Derived MicroRNA‐223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Kawasaki disease ( KD ) is now the most common cause of acquired cardiac disease in children due to permanent coronary artery damage with unknown etiology. The study sought to determine the role of blood micro RNA miR‐223 in KD and KD ‐induced injuries in vascular endothelial cells ( EC s) as well as the mechanisms involved. Methods and Results: Micro RNA profiles in serum from patients with KD and from healthy controls were assessed by microarray analysis. We noted that multiple serum micro RNA s were aberrantly expressed in KD , among them miR‐223, which was the most upregulated abundant serum micro RNA . We found that bone marrow–derived blood cells (leukocytes and platelets) were able to secrete miR‐223 into serum. Vascular EC s had no endogenous miR‐223; however, the blood cell–secreted serum miR‐223 could enter into the vascular EC s in the vascular walls. The exogenous miR‐223 had strong biological effects on EC functions via its target genes such as IGF 1R. Interestingly, KD ‐induced EC injuries were related to increased miR‐223 because they were inhibited by miR‐223 knockdown. Finally, these observations were verified using miR‐223 knockout mice and the chimeric mice generated by transplantation of bone marrow from miR‐223 knockout mice into wild‐type mice. Conclusions: In KD patients, the levels of blood cell–derived miR‐223 in EC s are significantly increased. The increased miR‐223 in EC s could work as a novel endocrine genetic signal and participate in vascular injury of KD . MiR‐223 may provide a novel mechanism and a new therapeutic target for vascular complication of KD .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previously, different studies have shown that miR-223-3p is an important regulator of vascular endothelial injury in Kawasaki Disease (KD) 38, 61, 62.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
Tabet, F., Vickers, K. C., Cuesta Torres, L. F., Wiese, C. B., Shoucri, B. M., Lambert, G., Catherinet, C., Prado-Lourenco, L., Levin, M. G., Thacker, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4292 · Cited by 428 · cited 1×
“However, blood cell–released miRNAs bind easily with microparticles, and other proteins like highdensity lipoprotein are within microparticles when they are released from the cells.(6,7,24) The microparticles and proteins binding miRNAs are stable and could easily enter into ECs.”
Background
Research works printed but not linked: 24
- 10.1016/j.jacc.2015.12.073 · DOI · Paper page
- 10.1111/apa.13367 · DOI
- 10.1152/physiolgenomics.00080.2009 · DOI
- 10.1007/s12265-010-9164-z · DOI
- 10.1097/FJC.0b013e318203759b · DOI
- 10.1042/CS20090645 · DOI · Paper page
- 10.1016/j.yjmcc.2012.08.010 · DOI · Paper page
- 10.1007/s12265-013-9493-9 · DOI
- 10.1161/CIRCRESAHA.111.247452 · DOI · Paper page
- 10.1126/science.1091903 · DOI · Paper page
- 10.1161/CIRCRESAHA.106.141986 · DOI · Paper page
- 10.1016/j.jacc.2015.03.570 · DOI
- 10.1097/CCM.0000000000001629 · DOI
- 10.1038/nm810 · DOI · Paper page
- 10.1161/ATVBAHA.109.188839 · DOI · Paper page
- 10.1016/j.yjmcc.2011.11.008 · DOI · Paper page
- 10.1007/s10495-011-0634-9 · DOI
- 10.1182/blood-2013-03-492801 · DOI · Paper page
- 10.1182/blood-2011-08-373886 · DOI · Paper page
- 10.1007/s00246-013-0846-6 · doi:10.1007/s00246-013-0846-6
- 10.1097/INF.0000000000000449 · DOI
- 10.1371/journal.pone.0058159 · DOI
- Rong X, Jia L, Hong L, Pan L, Xue X, Zhang C, Lu J, Jin Z, Qiu H, Wu R, Chu M. Serum miR‐92a‐3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions. J Cardiovasc Transl Res. 2016. Available at: http://link.springer.com/article/10.1007/s12265-016-9717-x. Accessed January 19, 2016. · doi:10.1007/s12265-016-9717-x
- 10.1006/jmcc.2001.1441 · DOI
Cited by
Kawasaki disease: pathophysiology and insights from mouse models
Noval Rivas, M., & Arditi, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0426-0 · Cited by 310
Jia, C., Zhang, J., Chen, H., Zhuge, Y., Chen, H., Qian, F., Zhou, K., Niu, C., Wang, F., Qiu, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2021-3 · Cited by 275
Self-citationmiR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
“Previously, different studies have shown that miR-223-3p is an important regulator of vascular endothelial injury in Kawasaki Disease (KD) [38, 61, 62].”
Background
Metadata
- Authors
- Chu, M., Wu, R., Qin, S., Hua, W., Shan, Z., Rong, X., Zeng, J., Hong, L., Sun, Y., Liu, Y., Li, W., Wang, S., & Zhang, C.
- Affiliations
- Children's Heart Center, The Second Affiliated Hospital & Yuying Children's Hospital, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China
- Department of Biomedical Engineering, School of Medicine, The University of Alabama at Birmingham, AL
- Division of Vascular Surgery and the Laboratory of General Surgery, First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, China
- Venue
- Journal of the American Heart Association
- Published
- 2017-02-02
- Volume
- 6
- Issue
- 2
- ISSN
- 2047-9980
- Cited by
- 55
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone Marrow–Derived MicroRNA‐223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease. https://app.cochat.ai/papers/10.1161/jaha.116.004878
- The paper
- Chu, M., Wu, R., Qin, S., Hua, W., Shan, Z., Rong, X., Zeng, J., Hong, L., Sun, Y., Liu, Y., Li, W., Wang, S., & Zhang, C. (2017). Bone Marrow–Derived MicroRNA‐223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.116.004878
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.